These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9673393)
1. Synthetic analogs of vitamin D3 have inhibitory effects on breast cancer cell lines. Fioravanti L; Miodini P; Cappelletti V; DiFronzo G Anticancer Res; 1998; 18(3A):1703-8. PubMed ID: 9673393 [TBL] [Abstract][Full Text] [Related]
2. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines. Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102 [TBL] [Abstract][Full Text] [Related]
3. Vitamin D3 analogs and their 24-oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects. Campbell MJ; Reddy GS; Koeffler HP J Cell Biochem; 1997 Sep; 66(3):413-25. PubMed ID: 9257197 [TBL] [Abstract][Full Text] [Related]
4. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells. Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668 [TBL] [Abstract][Full Text] [Related]
5. 19-nor-hexafluoride analogue of vitamin D3: a novel class of potent inhibitors of proliferation of human breast cell lines. Koike M; Elstner E; Campbell MJ; Asou H; Uskokovic M; Tsuruoka N; Koeffler HP Cancer Res; 1997 Oct; 57(20):4545-50. PubMed ID: 9377567 [TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft. Evans SR; Schwartz AM; Shchepotin EI; Uskokovic M; Shchepotin IB Clin Cancer Res; 1998 Nov; 4(11):2869-76. PubMed ID: 9829754 [TBL] [Abstract][Full Text] [Related]
7. Growth inhibition of HT-29 human colon cancer cells by analogues of 1,25-dihydroxyvitamin D3. Shabahang M; Buras RR; Davoodi F; Schumaker LM; Nauta RJ; Uskokovic MR; Brenner RV; Evans SR Cancer Res; 1994 Aug; 54(15):4057-64. PubMed ID: 8033137 [TBL] [Abstract][Full Text] [Related]
8. Autocrine TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in breast cells. Yang L; Yang J; Venkateswarlu S; Ko T; Brattain MG J Cell Physiol; 2001 Sep; 188(3):383-93. PubMed ID: 11473365 [TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Swami S; Krishnan AV; Feldman D Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825 [TBL] [Abstract][Full Text] [Related]
10. 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. Hisatake J; Kubota T; Hisatake Y; Uskokovic M; Tomoyasu S; Koeffler HP Cancer Res; 1999 Aug; 59(16):4023-9. PubMed ID: 10463602 [TBL] [Abstract][Full Text] [Related]
11. Osteoblast-derived growth factors enhance adriamycin-cytostasis of MCF-7 human breast cancer cells. Choki I; Sourla A; Reyes-Moreno C; Koutsilieris M Anticancer Res; 1998; 18(6A):4213-24. PubMed ID: 9891470 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Díaz GD; Paraskeva C; Thomas MG; Binderup L; Hague A Cancer Res; 2000 Apr; 60(8):2304-12. PubMed ID: 10786699 [TBL] [Abstract][Full Text] [Related]
13. Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1 alpha,25-dihydroxyvitamin D3 analogs: structure-function relationships. Bischof MG; Redlich K; Schiller C; Chirayath MV; Uskokovic M; Peterlik M; Cross HS J Pharmacol Exp Ther; 1995 Dec; 275(3):1254-60. PubMed ID: 8531089 [TBL] [Abstract][Full Text] [Related]
14. 1Alpha,25dihydroxyvitamin D3 and platinum drugs act synergistically to inhibit the growth of prostate cancer cell lines. Moffatt KA; Johannes WU; Miller GJ Clin Cancer Res; 1999 Mar; 5(3):695-703. PubMed ID: 10100724 [TBL] [Abstract][Full Text] [Related]
15. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion. Hedlund TE; Moffatt KA; Uskokovic MR; Miller GJ Clin Cancer Res; 1997 Aug; 3(8):1331-8. PubMed ID: 9815816 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53. Mathiasen IS; Lademann U; Jäättelä M Cancer Res; 1999 Oct; 59(19):4848-56. PubMed ID: 10519395 [TBL] [Abstract][Full Text] [Related]
17. Growth factors and chemotherapeutic modulation of breast cancer cells. Ciftci K; Su J; Trovitch PB J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904 [TBL] [Abstract][Full Text] [Related]
18. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Gooch JL; Lee AV; Yee D Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635 [TBL] [Abstract][Full Text] [Related]
19. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Schwartz GG; Wang MH; Zang M; Singh RK; Siegal GP Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):727-32. PubMed ID: 9298581 [TBL] [Abstract][Full Text] [Related]
20. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Anzano MA; Smith JM; Uskoković MR; Peer CW; Mullen LT; Letterio JJ; Welsh MC; Shrader MW; Logsdon DL; Driver CL Cancer Res; 1994 Apr; 54(7):1653-6. PubMed ID: 8137276 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]